Veterinary Industry News
We’ve collected a selection of press releases and updates from our partners and colleagues in the veterinary industry. Clicking on these links will take you to the organization’s website or open a press release in a new window.
Press Releases & Industry Updates
New incidence map reveals upward trend in heartworm cases, with influx of heartworm-positive dogs and lack of prevention compliance cited as leading factors.
Following a new partnership announced earlier this year with Multi Radiance, Digatherm Thermal Imaging, leading provider of veterinary thermal imaging solutions, is transitioning to a new name - WellVu Thermal Imaging. WellVu is committed to providing thermal imaging technology and training solutions to health care professionals in human and animal health.
The ASV has just released the second edition of the Guidelines for Standards of Care in Animal Shelters. The Guidelines, created as a resource for the housing, husbandry, medical and behavioral care of shelter animals, have been updated to include expanded research and information in the field of shelter veterinary medicine.
The Association of Shelter Veterinarians (ASV) has launched the Journal of Shelter Medicine & Community Animal Health (JSMCAH)—the first academic journal devoted to shelter and community medicine. It will provide evidence-based research impacting the welfare of animals in shelters and communities for veterinarians around the world.
The symposium took place September 8-11, 2022 and featured 40 speakers from three continents. Highlights included the development of new animal models to allow the investigation of future preventives and treatments without the need for laboratory dogs and a call to develop better protocols for feline heartworm disease.
Merck Animal Health announced the launch of Nobivac® Intra-Trac® Oral BbPi, the first-of-its-kind oral Bordetella bronchiseptica-canine parainfluenza virus vaccine that offers mucosal protection with easy oral administration to more efficiently deliver broad protection for dogs while enhancing ease of use for veterinary clinicians.
Dr. Christine Klippen of Friendship Hospital for Animals, part of the Encore Vet network of hospitals, spearheaded the development of this trailblazing program. The program is designed to provide career development in emergency medicine, and will develop critical skills and medical advancement in emergency veterinary practice.
The annual Hill’s Global Symposium is back with up to 6.5 hours of free world-class, RACE-approved CE. This year’s focus is dermatology. Explore these 30-minute lectures from some of veterinary medicine’s most influential voices in dermatology and nutrition at your leisure, anywhere, anytime.
The grant program is intended to advance initiatives that increase the medicalization of cats. Grants of up to $20,000 will be awarded and can be applied across a broad array of topics that fit within the umbrella of healthcare for companion cats. The deadline for applications is October 15th, 2022.
The new program, Vetoquinol Rehabilitation Business Solution (VeRBS), will help veterinary clinics jump-start rehabilitation services by offering on-site training for staff and up to 140 hours of continuing education credits.
SignalPET announced its proposal for a retrospective study investigating case outcomes for patients with a radiographic finding of Two Populations of Small Intestine. This study will explore the diagnosis, additional diagnostics performed, treatments, and outcome of each case.
The 2022 AAFP/AAHA Antimicrobial Stewardship Guidelines present evidence-guided strategies that veterinarians and their teams can use to choose appropriate antimicrobial therapy that minimizes the development of antimicrobial resistance.
From Dr. Doug Mader comes a stirring account of his fight to protect his animal patients and human staff amid the Los Angeles riots of the early 1990s in his new memoir, The Vet at Noah's Ark. The book follows Dr. Mader and his staff over the course of a year at his inner-city Los Angeles area veterinary hospital.
Norbrook Inc. announced it has released the new, more affordable Enroflox® Chewable Tablets. These new tablets are a fluoroquinolone antibiotic designed to manage susceptible bacterial diseases in cats and dogs.
The new peer reviewed study, which examines the impact of Fortetropin® on the quality of life and mobility in arthritic, geriatric dogs, has been accepted in the Canadian Veterinary Journal. The study found statistically significant improvement of the mobility scores for dogs in the treatment group that received Fortetropin.
Approximately 10,000 veterinary professionals in Georgia, New York and Texas will gain complimentary access to the Listeners On Call platform. Members of each state’s veterinary medical association will be offered 4 hours per month at no charge to connect with one of LOC’s trained listeners.
The PLOS One publication details the largest clinical validation study ever performed in veterinary cancer diagnostics and demonstrates that the performance of the non-invasive liquid biopsy test OncoK9® mirrors that of leading multi-cancer early detection (MCED) tests for humans.
Norbrook Inc. announced it has released MidamoxTM, a topical parasite control solution. MidamoxTM is an affordable, bioequivalent alternative to the pioneer product, Advantage Multi® for Dogs and Cats.